Investor Stock List
Ranked #2,542 of 8,699 institutional investors

Rhenman & Partners Asset Management AB

Stockholm, V7

$881M
US stock portfolio at live prices · today −$1.3M (−0.14%)
Live prices, last trade 12:14 PM ET
Value at quarter end (Q3 2026)
$903M
Change from Q2 2026
−$156.5M (−14.77%)
Positions
85 · 14 new, 18 sold out
Filed
Nov 12, 2026

Not counted in the ranking: none$116M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
EW 3.21%MRK 3.17%INSM 3.10%GILD 3.05%VRTX 2.91%
StockSharesValue, live% of portfoliovs Q2 2026
EW Edwards Lifesciences Corporation273,000$28.3M3.21%Added +5%
MRK Merck & Co., Inc.206,900$27.9M3.17%Reduced −3%
INSM Insmed Incorporated187,080$27.4M3.10%Added +23%
GILD Gilead Sciences, Inc.159,050$26.9M3.05%Reduced −11%
VRTX Vertex Pharmaceuticals Incorporated48,935$25.6M2.91%Added +59%
LLY Eli Lilly and Company18,875$25.6M2.90%Reduced −15%
UNH UnitedHealth Group Incorporated71,400$24.7M2.80%Reduced −24%
BIIB Biogen Inc.97,050$24.2M2.75%Added +2%
BMRN BioMarin Pharmaceutical Inc.386,900$23.7M2.69%Added +33%
COR Cencora, Inc.62,478$21.5M2.44%Added +34%
MCK McKesson Corporation17,850$19.4M2.20%Added +8%
CVS CVS Health Corporation220,374$18.1M2.05%Reduced −21%
REGN Regeneron Pharmaceuticals, Inc.19,340$18.0M2.05%Reduced −29%
ABBV AbbVie Inc.61,625$17.8M2.02%Reduced −36%
IOVA Iovance Biotherapeutics, Inc.2,502,577$17.5M1.99%Added +47%
JNJ Johnson & Johnson58,500$15.9M1.80%Reduced −19%
CNC Centene Corporation237,481$15.5M1.76%Reduced −3%
DHR Danaher Corporation68,461$15.3M1.73%Reduced −15%
CRL Charles River Laboratories International, Inc.46,800$14.7M1.66%Reduced −18%
THC Tenet Healthcare Corporation52,787$13.9M1.58%Reduced −38%
PRCT PROCEPT BioRobotics Corporation535,000$13.7M1.56%Added +55%
ISRG Intuitive Surgical, Inc.33,500$13.6M1.54%Reduced −3%
BSX Boston Scientific Corporation315,000$13.5M1.53%Reduced −30%
A Agilent Technologies, Inc.78,000$13.3M1.51%Added +4%
AXSM Axsome Therapeutics, Inc.97,735$12.8M1.46%Added +55%
NBIX Neurocrine Biosciences, Inc.81,291$12.4M1.41%Reduced −5%
BTSG BrightSpring Health Services, Inc.192,896$12.3M1.39%Added +16%
GH Guardant Health, Inc.76,250$10.9M1.24%Reduced −34%
COO The Cooper Companies, Inc.181,500$10.8M1.23%Added +236%
UTHR United Therapeutics Corporation19,150$10.6M1.21%New
TMO Thermo Fisher Scientific Inc.15,563$10.5M1.20%Reduced −51%
ALHC Alignment Healthcare, Inc.1,380,295$9.1M1.03%Added +38%
MIRM Mirum Pharmaceuticals, Inc.91,855$9.0M1.02%Reduced −34%
EHC Encompass Health Corporation66,263$8.9M1.01%Reduced −11%
ERAS Erasca, Inc.608,750$8.5M0.97%Added +74%
PNTG The Pennant Group, Inc.236,499$8.2M0.93%Reduced −36%
AVR Anteris Technologies Global Corp.1,538,625$7.6M0.86%Unchanged
SYRE Spyre Therapeutics, Inc.78,600$7.4M0.84%Reduced −34%
HUM Humana Inc.17,000$6.8M0.77%New
DNTH Dianthus Therapeutics, Inc.75,027$6.3M0.72%Reduced −13%
VERA Vera Therapeutics, Inc.242,500$6.2M0.70%New
TGTX TG Therapeutics, Inc.90,500$5.8M0.66%Added +1,710%
DXCM DexCom, Inc.73,000$5.8M0.66%Reduced −54%
NRIX Nurix Therapeutics, Inc.439,500$5.7M0.65%Reduced −36%
OSCR Oscar Health, Inc.220,000$5.6M0.64%Reduced −44%
RLAY Relay Therapeutics, Inc.343,500$5.5M0.62%Reduced −39%
CYTK Cytokinetics, Incorporated102,800$5.3M0.60%New
ORKA Oruka Therapeutics, Inc.55,900$5.3M0.60%Reduced −30%
VCEL Vericel Corporation90,000$5.2M0.59%Added +29%
GKOS Glaukos Corporation22,000$5.2M0.59%Reduced −82%
ABT Abbott Laboratories49,500$5.2M0.59%Reduced −48%
ARWR Arrowhead Pharmaceuticals, Inc.112,500$4.8M0.55%Reduced −12%
AGL agilon health, inc.52,924$4.7M0.53%Added +958%
WAY Waystar Holding Corp.169,151$4.5M0.51%Reduced −5%
BBIO BridgeBio Pharma, Inc.57,100$4.4M0.50%Reduced −37%
PODD Insulet Corporation32,000$4.4M0.50%Reduced −24%
ALNY Alnylam Pharmaceuticals, Inc.25,900$3.9M0.44%Added +51%
IDYA IDEAYA Biosciences, Inc.140,185$3.6M0.41%Reduced −59%
KURA Kura Oncology, Inc.501,050$3.6M0.40%Reduced −15%
MBX MBX Biosciences, Inc.62,000$3.2M0.36%Unchanged
SNDX Syndax Pharmaceuticals, Inc.342,250$3.1M0.35%Reduced −39%
NKTR Nektar Therapeutics98,380$3.1M0.35%Reduced −30%
GPCR Structure Therapeutics Inc.183,300$3.0M0.34%Added +26%
OCUL Ocular Therapeutix, Inc.512,000$2.9M0.33%Added +128%
KRYS Krystal Biotech, Inc.8,225$2.6M0.29%Reduced −50%
INNV InnovAge Holding Corp.279,000$2.6M0.29%New
ASTH Astrana Health, Inc.79,574$2.3M0.27%Reduced −33%
MDGL Madrigal Pharmaceuticals, Inc.5,655$2.2M0.25%Reduced −30%
SMMT Summit Therapeutics Inc.215,000$2.2M0.25%New
RYTM Rhythm Pharmaceuticals, Inc.19,000$2.1M0.24%New
DNLI Denali Therapeutics Inc.113,585$2.1M0.24%Reduced −37%
ADPT Adaptive Biotechnologies Corporation72,500$2.0M0.23%New
PRVA Privia Health Group, Inc.66,000$1.7M0.19%Added +32%
STOK Stoke Therapeutics, Inc.61,000$1.7M0.19%Reduced −5%
TNGX Tango Therapeutics, Inc.60,000$1.3M0.15%New
XENE Xenon Pharmaceuticals Inc.33,700$1.3M0.14%Added +1%
ENSG The Ensign Group, Inc.3,750$667K<0.1%New
SYK Stryker Corporation1,000$315K<0.1%Reduced −98%
TXG 10x Genomics, Inc.5,300$277K<0.1%Reduced −38%
BBNX Beta Bionics, Inc.20,000$269K<0.1%New
CAI Caris Life Sciences, Inc.15,000$265K<0.1%New
BRKR Bruker Corporation4,500$259K<0.1%New
AMN AMN Healthcare Services, Inc.7,200$255K<0.1%Reduced −95%
SION Sionna Therapeutics, Inc.87,500$251K<0.1%Reduced −10%
SCI Service Corporation International3,200$227K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
NTRA Natera, Inc.61,050$16.8M
ELV Elevance Health, Inc.34,900$14.2M
ALGN Align Technology, Inc.63,000$9.9M
CAH Cardinal Health, Inc.22,500$6.2M
MLYS Mineralys Therapeutics, Inc.416,371$5.8M
MEDP Medpace Holdings, Inc.8,500$5.3M
AMGN Amgen Inc.11,900$5.2M
CI The Cigna Group17,400$4.9M
VEEV Veeva Systems Inc.17,300$4.6M
MOH Molina Healthcare, Inc.21,857$4.5M
MLTX MoonLake Immunotherapeutics384,800$4.2M
VKTX Viking Therapeutics, Inc.128,000$3.2M
DOCS Doximity, Inc.76,107$2.2M
IONS Ionis Pharmaceuticals, Inc.59,900$1.6M
MMED MiniMed Group, Inc.55,000$892K
BCAX Bicara Therapeutics Inc.88,150$782K
ATEC Alphatec Holdings, Inc.85,000$576K
TNDM Tandem Diabetes Care, Inc.20,000$349K